title: Standard management options for rosacea, part 2: options according to subtype.
abstract: The standard management options were developed by a consensus committee and review panel of 26 experts to assist in providing optimal patient care based on the standard classification and grading systems for rosacea that were developed to perform research; analyze results and compare data from different sources; and provide a common terminology and reference for the diagnosis, treatment, and assessment of results in clinical practice. We discuss the standard management options for rosacea in 2 parts: (1) overview and broad spectrum of care, and (2) management options according to subtype. The menu of options is considered provisional and may be expanded and updated as appropriate. Managing the various potential signs and symptoms of rosacea calls for consideration of a broad spectrum of care, and a more precise selection of therapeutic options may become increasingly possible as the mechanisms of action of therapies are more definitively established.
authors.affiliation: Department of Dermatology, University of California, San Francisco, USA. nrosacea@aol.com
authors.forename: Richard
authors.initials: R
authors.lastname: Odom
authors.forename: Mark
authors.initials: M
authors.lastname: Dahl
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Dover
authors.forename: Zoe
authors.initials: Z
authors.lastname: Draelos
authors.forename: Lynn
authors.initials: L
authors.lastname: Drake
authors.forename: Marian
authors.initials: M
authors.lastname: Macsai
authors.forename: Frank
authors.initials: F
authors.lastname: Powell
authors.forename: Diane
authors.initials: D
authors.lastname: Thiboutot
authors.forename: Guy F
authors.initials: GF
authors.lastname: Webster
authors.forename: Jonathan
authors.initials: J
authors.lastname: Wilkin
mesh_terms: D004890:Erythema / Q000209:etiology / Q000473:pathology / Q000628:therapy; D005128:Eye Diseases / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D012224:Rhinophyma / Q000473:pathology / Q000628:therapy; D012393:Rosacea / Q000145:classification / Q000473:pathology / Q000628:therapy*; D012720:Severity of Illness Index; D017592:Skin Care / Q000379:methods*; D013684:Telangiectasis / Q000209:etiology / Q000473:pathology / Q000628:therapy